Insights into South Africa’s evolving healthcare landscape
Africa is playing an increasingly important role in global healthcare and clinical research. With a rapidly growing population, a significant share of the global disease burden, and rising levels of investment, the region is becoming central to discussions around the future of healthcare delivery and innovation. This growing importance presents both an opportunity and a responsibility to strengthen systems, infrastructure, and collaboration across the continent.
From hosting the world's first human heart transplant to launching Africa's first public-sector robotic surgery programme, the Groote Schuur Hospital (GSH) in Cape Town is a testament to South Africa's pioneering medical advancements. Image credit: Danie van der MerweCamera location33° 56' 27.9? S, 18° 27' 41.99? E View this and other nearby images on: OpenStreetMap-33.941083; 18.461664, CC BY 2.0, via Wikimedia Commons
Against this backdrop, SAPHEX, an event for the pharmaceutical manufacturing industry in South Africa and the SADC region, offers a valuable lens on the industry's current state.
Bringing together pharmaceutical manufacturers, supply chain specialists, healthcare providers, IT and digital health companies, as well as government bodies and regulators, this event reflects a life sciences sector that is becoming more digital, more interconnected, and increasingly collaborative.
Key takeaways from SAPHEX 2026
One of the most prominent themes at SAPHEX 2026 was the growing role of digitalisation across the healthcare ecosystem.
The expansion of digital health solutions and data-driven decision-making is transforming how organisations operate, with IT players becoming more integrated alongside traditional pharmaceutical and healthcare stakeholders.
This shift is driving greater efficiency and transparency, while also supporting improved patient outcomes.
At the same time, pharmaceutical manufacturing is evolving to meet growing demand and the need for innovation.
There is a clear focus on packaging advancements, modern equipment, and enhanced production capabilities, all aimed at improving scalability, efficiency, and quality across the value chain.
Intergrating and collaborating
Another defining takeaway from the event is the emergence of a more integrated and collaborative healthcare landscape.
Strong representation from regulators and public sector organisations signalled greater alignment across the ecosystem.
Increasingly, pharmaceutical manufacturers, logistics providers, and regulators such as the South African Health Products Regulatory Authority (SAHPRA) are working together more closely.
This trend, reinforced through industry discussions and wider engagement, highlights a growing recognition that collaboration is essential to improving access, quality, and patient outcomes across Africa.
It is also critical for expanding clinical trials beyond South Africa and addressing existing equity and access gaps across the continent.
Prioritising logistics
Alongside these developments, logistics is emerging as a strategic priority. It is no longer viewed solely as an operational function but as a key enabler of clinical trial delivery, healthcare access, and overall supply chain resilience.
Effective logistics ensures temperature-controlled transport, regulatory compliance, and continuity of patient care, all of which are essential in increasingly complex healthcare environments.
Ongoing challenges
Despite this growing recognition, SAPHEX also highlighted several ongoing challenges faced by stakeholders within life science logistics.
Issues include the affordability and availability of specialised courier services, missed collections, delays in reaching remote areas, and limited access to compliant packaging solutions.
These challenges have direct implications for both healthcare delivery and research.
Delays to clinical studies and time-sensitive shipments can disrupt timelines, while increased costs and operational inefficiencies place additional strain on organisations.
More critically, risks to temperature-sensitive samples can compromise product integrity and patient safety.
In some cases, these logistical barriers can also contribute to delays in regulatory approvals, further impacting the progress of clinical trials and access to new treatments.
Central role of logistics
As the industry continues to evolve, the role of logistics is becoming increasingly central, as it plays a critical role in enabling clinical trial execution, ensuring reliable healthcare delivery, and maintaining end-to-end supply chain performance.
This is particularly important in regions where infrastructure, geography, and regulatory complexity can present additional challenges.
There is a growing emphasis on compliance-driven processes, the careful handling of temperature-sensitive materials, and the need for consistency and reliability across diverse and often hard-to-reach locations.
In this context, logistics providers are expected not only to deliver efficiently but also to operate with a high level of expertise and adaptability.
Future of life science logistics
Expectations of logistics providers are continuing to rise, driven in large part by digitalisation.
There is increasing demand for real-time tracking, end-to-end shipment visibility, and faster, more responsive delivery solutions.
At the same time, organisations require reliable handling of temperature-sensitive and time-critical materials, with no compromise on compliance or quality.
Transparency, accountability, and data-driven performance are becoming standard expectations across the industry.
Sustainability is also emerging as a key consideration. Companies are placing greater emphasis on environmentally responsible logistics practices, including reducing packaging waste, optimising transport routes, and improving the sustainability of cold chain operations.
However, these efforts must be carefully balanced with regulatory requirements, product integrity, and operational reliability, particularly in highly sensitive healthcare environments.
Alongside technological and operational advancements, people remain at the centre of progress.
The continued development of a skilled and diverse workforce across South Africa is playing a vital role in supporting the sector’s growth.
Diverse, locally rooted teams bring valuable expertise and insight, supporting operational excellence, strengthening resilience, and enabling long-term impact across the healthcare ecosystem.
Digital, interconnected, and collaborative
SAPHEX signals a healthcare ecosystem that is becoming more digital, interconnected, and collaborative.
As Africa continues to grow in importance within global healthcare and clinical research, the need for strong infrastructure, local expertise, and cross-border collaboration will become increasingly critical.
Sustained progress will depend on the ability of organisations to invest in partnerships, technology, and logistics solutions that are not only reliable and compliant but also adaptable and sustainable.
For logistics providers, this means continuing to deliver specialist expertise and locally informed support to meet the evolving needs of the life sciences sector, while supporting the next phase of healthcare advancement across South Africa and the wider continent.
About the author
Christopher Perumal is the country director of Africa at Biocair.